China Biotech Services Holdings Limited (HKG:8037)
Hong Kong
· Delayed Price · Currency is HKD 0.670
+0.010 (1.52%)
Apr 29, 2026, 3:54 PM HKT
HKG:8037 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 654 | 771 | 498 | 742 | 1,108 | 1,329 | Upgrade
|
| Market Cap Growth | 67.50% | 54.90% | -32.91% | -33.04% | -16.67% | 5.85% | Upgrade
|
| Enterprise Value | 1,001 | 946 | 622 | 678 | 1,090 | 1,342 | Upgrade
|
| Last Close Price | 0.67 | 0.79 | 0.51 | 0.77 | 1.14 | 1.37 | Upgrade
|
| PE Ratio | - | - | - | - | 4.29 | 68.57 | Upgrade
|
| PS Ratio | 8.89 | 10.49 | 7.06 | 3.50 | 0.60 | 2.13 | Upgrade
|
| PB Ratio | 4.20 | 4.95 | 2.05 | 1.51 | 1.34 | 2.85 | Upgrade
|
| P/TBV Ratio | 12.87 | 15.17 | 3.95 | 2.49 | 2.61 | 6.86 | Upgrade
|
| P/FCF Ratio | - | - | - | 5.61 | 2.96 | 46.99 | Upgrade
|
| P/OCF Ratio | - | - | - | 3.87 | 2.30 | 32.82 | Upgrade
|
| EV/Sales Ratio | 13.62 | 12.87 | 8.83 | 3.20 | 0.59 | 2.15 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 1.21 | 5.48 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 1.29 | 7.08 | Upgrade
|
| EV/FCF Ratio | - | - | - | 5.12 | 2.91 | 47.43 | Upgrade
|
| Debt / Equity Ratio | 2.54 | 2.54 | 0.78 | 0.21 | 0.10 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.09 | 0.26 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.76 | 0.22 | 2.37 | Upgrade
|
| Net Debt / Equity Ratio | 2.46 | 2.46 | 0.70 | 0.06 | -0.01 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.42 | -6.42 | -1.28 | -0.39 | -0.01 | -0.35 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -0.83 | 0.21 | -0.03 | -3.01 | Upgrade
|
| Asset Turnover | 0.12 | 0.12 | 0.12 | 0.20 | 1.70 | 0.77 | Upgrade
|
| Inventory Turnover | 3.22 | 3.22 | 11.39 | 12.69 | 63.98 | 51.75 | Upgrade
|
| Quick Ratio | 0.07 | 0.07 | 0.23 | 0.73 | 1.54 | 1.09 | Upgrade
|
| Current Ratio | 0.23 | 0.23 | 0.33 | 1.64 | 1.61 | 1.22 | Upgrade
|
| Return on Equity (ROE) | -40.61% | -40.61% | -68.71% | -21.36% | 109.19% | 27.11% | Upgrade
|
| Return on Assets (ROA) | -7.49% | -7.49% | -15.34% | -6.85% | 48.39% | 14.71% | Upgrade
|
| Return on Invested Capital (ROIC) | -13.71% | -15.55% | -31.45% | -17.51% | 115.24% | 45.35% | Upgrade
|
| Return on Capital Employed (ROCE) | -20.70% | -20.70% | -43.40% | -23.20% | 91.40% | 39.50% | Upgrade
|
| Earnings Yield | -10.52% | -8.92% | -39.82% | -12.87% | 23.30% | 1.46% | Upgrade
|
| FCF Yield | - | - | -40.90% | 17.84% | 33.81% | 2.13% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.88% | - | Upgrade
|
| Buyback Yield / Dilution | -0.75% | -0.75% | -0.55% | - | 0.15% | 0.39% | Upgrade
|
| Total Shareholder Return | -0.75% | -0.75% | -0.55% | - | 1.03% | 0.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.